Rachel King
DirectoratFulcrum Therapeutics· In proxies 2023–2025
Rachel King sits on 2 public boards.
Boards1
- Fulcrum TherapeuticsDirector · 0 yr on the boardIndependentCompensation and Human Capital Management—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Fulcrum TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -43%
- NovavaxPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Crescent BiopharmaPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?